Search

Thuy V Tran

Examiner (ID: 6857, Phone: (571)272-1828 , Office: P/2844 )

Most Active Art Unit
2821
Art Unit(s)
2821, 2844, 2856, 2814
Total Applications
2202
Issued Applications
1909
Pending Applications
47
Abandoned Applications
246

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17228589 [patent_doc_number] => 20210355145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-18 [patent_title] => PROCESS FOR PRODUCING DIMETHYLCHLOROSILANE COMPOUND [patent_app_type] => utility [patent_app_number] => 17/307178 [patent_app_country] => US [patent_app_date] => 2021-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4197 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17307178 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/307178
PROCESS FOR PRODUCING DIMETHYLCHLOROSILANE COMPOUND May 3, 2021 Abandoned
Array ( [id] => 17020883 [patent_doc_number] => 20210244754 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-12 [patent_title] => DEOXYNUCLEOSIDE THERAPY FOR DISEASES CAUSED BY UNBALANCED NUCLEOTIDE POOLS INCLUDING MITOCHONDRIAL DNA DEPLETION SYNDROMES [patent_app_type] => utility [patent_app_number] => 17/242822 [patent_app_country] => US [patent_app_date] => 2021-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9856 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17242822 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/242822
Deoxynucleoside therapy for diseases caused by unbalanced nucleotide pools including mitochondrial DNA depletion syndromes Apr 27, 2021 Issued
Array ( [id] => 17183794 [patent_doc_number] => 20210330679 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-28 [patent_title] => PLATINUM-ACRIDINE COMPOUNDS AND METHODS OF TREATING CANCERS [patent_app_type] => utility [patent_app_number] => 17/235382 [patent_app_country] => US [patent_app_date] => 2021-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23395 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17235382 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/235382
Platinum-acridine compounds and methods of treating cancers Apr 19, 2021 Issued
Array ( [id] => 17005365 [patent_doc_number] => 20210236526 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-05 [patent_title] => IMMUNOMODULATORY OLIGOSACCHARIDES [patent_app_type] => utility [patent_app_number] => 17/231336 [patent_app_country] => US [patent_app_date] => 2021-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15531 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231336 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/231336
IMMUNOMODULATORY OLIGOSACCHARIDES Apr 14, 2021 Abandoned
Array ( [id] => 18603372 [patent_doc_number] => 11744812 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-09-05 [patent_title] => Methods of treatment [patent_app_type] => utility [patent_app_number] => 17/231716 [patent_app_country] => US [patent_app_date] => 2021-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38979 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231716 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/231716
Methods of treatment Apr 14, 2021 Issued
Array ( [id] => 17005366 [patent_doc_number] => 20210236527 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-08-05 [patent_title] => IMMUNOMODULATORY OLIGOSACCHARIDES [patent_app_type] => utility [patent_app_number] => 17/231367 [patent_app_country] => US [patent_app_date] => 2021-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15608 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17231367 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/231367
IMMUNOMODULATORY OLIGOSACCHARIDES Apr 14, 2021 Abandoned
Array ( [id] => 16991958 [patent_doc_number] => 20210230378 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-29 [patent_title] => GEL COMPOSITION AND PRODUCTION METHOD THEREFOR [patent_app_type] => utility [patent_app_number] => 17/229978 [patent_app_country] => US [patent_app_date] => 2021-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10759 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17229978 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/229978
Gel composition and production method therefor Apr 13, 2021 Issued
Array ( [id] => 16976076 [patent_doc_number] => 20210220313 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-22 [patent_title] => FORMULATION AND METHOD FOR THE PREVENTION AND/OR TREATMENT OF HANGOVER SYMPTOMS [patent_app_type] => utility [patent_app_number] => 17/227020 [patent_app_country] => US [patent_app_date] => 2021-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7901 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17227020 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/227020
Formulation and method for the prevention and/or treatment of hangover symptoms Apr 8, 2021 Issued
Array ( [id] => 18525465 [patent_doc_number] => 11712443 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-01 [patent_title] => 17a-monoesters and 17a,21-diesters of cortexolone for use in the treatment of tumors [patent_app_type] => utility [patent_app_number] => 17/223776 [patent_app_country] => US [patent_app_date] => 2021-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 27 [patent_no_of_words] => 18400 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17223776 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/223776
17a-monoesters and 17a,21-diesters of cortexolone for use in the treatment of tumors Apr 5, 2021 Issued
Array ( [id] => 17370388 [patent_doc_number] => 20220025440 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-27 [patent_title] => LABELLING COMPOUNDS AND THEIR USE IN ASSAYS [patent_app_type] => utility [patent_app_number] => 17/222484 [patent_app_country] => US [patent_app_date] => 2021-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15358 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17222484 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/222484
Labelling compounds and their use in assays Apr 4, 2021 Issued
Array ( [id] => 17156095 [patent_doc_number] => 20210317146 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-14 [patent_title] => COMPOSITIONS AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF MITOCHONDRIAL DISEASE, INCLUDING FRIEDREICH'S ATAXIA [patent_app_type] => utility [patent_app_number] => 17/221463 [patent_app_country] => US [patent_app_date] => 2021-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 45192 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -45 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17221463 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/221463
Compositions and methods for the prevention and/or treatment of mitochondrial disease, including Friedreich's ataxia Apr 1, 2021 Issued
Array ( [id] => 17126631 [patent_doc_number] => 20210301400 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-30 [patent_title] => PRECURSORS AND METHODS FOR PREPARING SILICON-CONTAINING FILMS [patent_app_type] => utility [patent_app_number] => 17/214701 [patent_app_country] => US [patent_app_date] => 2021-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4304 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17214701 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/214701
Precursors and methods for preparing silicon-containing films Mar 25, 2021 Issued
Array ( [id] => 16948095 [patent_doc_number] => 20210206786 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-08 [patent_title] => N-ALKYL SUBSTITUTED CYCLIC AND OLIGOMERIC PERHYDRIDOSILAZANES, METHODS OF PREPARATION THEREOF, AND SILICON NITRIDE FILMS FORMED THEREFROM [patent_app_type] => utility [patent_app_number] => 17/210652 [patent_app_country] => US [patent_app_date] => 2021-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3002 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17210652 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/210652
N-alkyl substituted cyclic and oligomeric perhydridosilazanes, methods of preparation thereof, and silicon nitride films formed therefrom Mar 23, 2021 Issued
Array ( [id] => 16930779 [patent_doc_number] => 20210196668 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-01 [patent_title] => TIGLIEN-3-ONE DERIVATIVES [patent_app_type] => utility [patent_app_number] => 17/204747 [patent_app_country] => US [patent_app_date] => 2021-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16716 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17204747 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/204747
TIGLIEN-3-ONE DERIVATIVES Mar 16, 2021 Abandoned
Array ( [id] => 17141620 [patent_doc_number] => 20210309632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-10-07 [patent_title] => 4-(3-CYANOPHENYL)-6-PYRIDINYLPYRIMIDINE MGLU5 MODULATORS [patent_app_type] => utility [patent_app_number] => 17/203146 [patent_app_country] => US [patent_app_date] => 2021-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14381 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17203146 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/203146
Methods of treatment using 4-(3-cyanophenyl)-6-pyridinylpyrimidine mGlu5 modulators Mar 15, 2021 Issued
Array ( [id] => 18664813 [patent_doc_number] => 11771678 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-10-03 [patent_title] => Therapeutic agent for neuropathy in organic acidemia of which mechanism relies on increase in cAMP [patent_app_type] => utility [patent_app_number] => 17/198904 [patent_app_country] => US [patent_app_date] => 2021-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 7680 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17198904 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/198904
Therapeutic agent for neuropathy in organic acidemia of which mechanism relies on increase in cAMP Mar 10, 2021 Issued
Array ( [id] => 17082019 [patent_doc_number] => 20210277025 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-09 [patent_title] => BIONANOCOMPOSITE AND METHOD THEREOF [patent_app_type] => utility [patent_app_number] => 17/196233 [patent_app_country] => US [patent_app_date] => 2021-03-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4205 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17196233 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/196233
BIONANOCOMPOSITE AND METHOD THEREOF Mar 8, 2021 Pending
Array ( [id] => 16913790 [patent_doc_number] => 20210186882 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => FREEZE-DRIED ALGINIC ACID PREPARATION [patent_app_type] => utility [patent_app_number] => 17/194742 [patent_app_country] => US [patent_app_date] => 2021-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5368 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17194742 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/194742
FREEZE-DRIED ALGINIC ACID PREPARATION Mar 7, 2021 Abandoned
Array ( [id] => 17065792 [patent_doc_number] => 20210268007 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-09-02 [patent_title] => TREATMENT OF TRIPLE NEGATIVE BREAST CANCER [patent_app_type] => utility [patent_app_number] => 17/190317 [patent_app_country] => US [patent_app_date] => 2021-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10079 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17190317 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/190317
Pivarubicin and benzarubicin compositions Mar 1, 2021 Issued
Array ( [id] => 16913906 [patent_doc_number] => 20210186998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-06-24 [patent_title] => COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS [patent_app_type] => utility [patent_app_number] => 17/185734 [patent_app_country] => US [patent_app_date] => 2021-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20461 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17185734 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/185734
COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS Feb 24, 2021 Abandoned
Menu